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Summary 
 
Hair analysis for abstinence testing has been gaining ever more traction as an alternative to 
classic matrices such as blood or urine due to the many benefits it offers, the most important 
being a long window of detection. However, hair analysis still suffers from a lack of 
knowledge concerning the factors that can influence the concentrations ultimately found in 
the hair. One such influencing factor, and the topic of this thesis, is the sampling location on 
the head. This topic had been examined by Dussy et al. 2014 in a small study. The study had a 
small sample size of three test subjects and did not investigate the entire head systematically. 
Additionally, only ethyl glucuronide (EtG) and caffeine were investigated. Therefore, little 
could be said about the patterns of distribution or the possible extent of differences, especially 
about any other substance than EtG and caffeine. 
In a first step, the entire scalp hair of a single person was investigated. For this, the scalp hair 
was divided into individual strands of roughly 3x3 cm area yielding a total of 104 strands 
across the head. Each strand was analyzed for EtG and caffeine. For this, a method for the 
analysis of EtG using LC-MS
3
 was developed, as the previous employed GC-MS/MS method 
was not suitable for large series of samples. The complete analysis yielded EtG concentrations 
between 6.8 and 20.2 pg/mg. For caffeine, values between 1.1 and 12.0 ng/mg were obtained. 
The distribution patterns of EtG and caffeine were markedly different. While caffeine clearly 
showed higher concentrations towards the edges of the haircut, EtG was not as clearly 
distributed except for lower concentration at the neck.  
As these results were very promising, the distribution was investigated more thoroughly. 
Cocaine is the second most important substance for hair analysis after EtG at our lab, as it is 
the most prevalent in the routine population. Therefore, the study focused on alcohol and 
cocaine consuming individuals. For each individual, all hair was sampled in the same way as 
in the previous single person study. As the sample preparation for EtG and drugs of abuse 
(DoA) was normally done with different methods at our lab, the analysis of the many 
hundreds to thousands of hair samples would have exceeded the manageable workload. 
Therefore, a combined sample preparation method for EtG, caffeine, DoA and 
benzodiazepines/z-substances (BZD-Z) was developed. The method is based on the different 
retention characteristics of the substances to an Oasis Max SPE cartridge. Using this 
combined sample preparation, a large workload reduction was possible. Also in cases with 
little available hair, a full analysis was still possible.  
In addition to determining the shape and extent of the substance distributions, finding 
explanations for the observed differences was of interest. Therefore, in cooperation with the 
clinic for angiology and the department for sport, exercise and health, the head skin perfusion 
and sweating rates across the scalp were investigated, as the bloodstream and the sweat are 
thought to be important incorporation pathways. The head skin perfusion was measured using 
a laser Doppler anemometer. Each sample area was scanned allowing the same cartography of 
the perfusion rates as with the substance concentrations. The head skin sweating rates were 
measured using a cycling cap which was lined with pads of strongly water absorbing material. 
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The test subjects were asked to cycle for 10 minutes on an ergometer after which the cycling 
cap was placed on their head and another 10 minutes of cycling were commenced. The weight 
of the pads was measured before and after cycling to obtain the weight of the excreted sweat.  
Thirteen alcohol and/or drug consuming persons, 12 of which were cocaine consumers and 9 
of which were alcohol consumers could be enlisted. The distribution patterns for 29 different 
substances were obtained. For many substances (almost all DoA and BZD-Z) the distribution 
showed a clear pattern of higher concentrations on the periphery of the head and especially on 
the forehead. EtG in general showed a reverse behavior to this, with higher concentrations 
towards the vertex posterior region. The extent of the found differences across the head was 
depended strongly on substance and on the individual. Cocaine showed factors between 2.8 
and 105 (median 8.4) between lowest and highest concentrations, while e.g. methadone 
showed factors of only 1.6 to 4.2 (median 2.0). EtG showed factors between 2.5 and 7.1 
(median 4.0). These differences are very relevant as typically cut-off thresholds are applied 
when evaluating hair results. This leads to situations in which results of samples from 
different parts of the head lead to a different evaluation of the consumption habits. In the case 
of EtG, two thresholds (7 pg/mg [5 pg/mg according to the new SoHT consensus of 
06.08.2019] and 30 pg/mg for abstinence and chronic excessive consumption, respectively) 
are applied. One participant showed concentrations between 6.2 pg/mg and 30.4 pg/mg. For 
this participant, depending on sampling location, the whole range of interpretations is possible 
if applying the former cut-offs. For seven of nine study participants, the EtG concentrations 
fell into more than one category. This is problematic and should be considered when sampling 
and documenting sampling in routine work. The perfusion measurements did not show a clear 
pattern of perfusion rates, with only the back of the neck showing significantly lower 
perfusion rates across participants. The sweat rates showed large differences with sweating 
being highest on the forehead and generally decreasing towards the vertex posterior. The 
sweat rates showed a similar behavior to the concentrations of most substances, meaning the 
concentration differences could be caused by sweating. EtG showed a reverse distribution to 
the sweat rates, so might instead be washed out by the sweat.  
From these results, sweat rate differences across the scalp are believed to be a major source of 
the observed concentration differences. For sweat to be a major incorporation pathway, 
substances must on the one hand be able to cross from the bloodstream into the sweat, and on 
the other be able to go from the sweat into the hair. Most research studying the incorporation 
of substances from the sweat into the hair were conducted within the context of external 
contamination. Therefore, these studies usually focused on cocaine and employed high 
concentrations and unrealistic conditions for modeling the daily incorporation from sweat of a 
drug user. On this basis, the incorporation of the routine panel of substances into the hair from 
artificial sweat solution was investigated to test the plausibility of the hypothesis that sweat is 
a major contributor to the concentration differences found across the head. This project is 
currently ongoing and definite results are not yet available. 
One study participant reported consuming Kratom every day. As mitragynine and 7-
hydroxymitragynine (7-Hy-Mitra) have recently been listed as scheduled substances in 
Switzerland, a method was developed for the measurement of mitragynine and 7-Hy-Mitra in 
hair and applied to the hair of the study participant. 7-Hy-Mitra could not be detected in any 
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sample. Mitragynine showed a narrow concentration distribution with concentrations between 
1.1 ng/mg and 2.2 ng/mg with no clear pattern. The method was applied to routine drug of 
abuse hair samples to estimate the prevalence of Kratom consumption. After measurement of 
300 routine samples, not a single sample was positive, showing a low prevalence of Kratom 
consumption.  
Recently, hemp material containing less than 1 % THC and high amounts of cannabidiol 
(CBD) have become available for legal purchase in Switzerland. No information was 
available if smoking this CBD rich hemp could yield THC concentrations above the legal cut-
off of 1.5 ng/mL in blood (2.2 ng/mL with the confidence interval; VRV Art. 2 § 2). 
Therefore, a self-experiment was conducted to determine if concentrations above this legal 
limit could be reached. In this experiment, an employee of our institute smoked a CBD joint 
while blood was collected at regular intervals. Urine was collected from every spontaneous 
void. To see if an accumulation of THC could occur, the same person smoked two CBD joints 
per day for ten day. While smoking the last joint, blood and urine were again collected. The 
experiment showed that blood concentrations above the legal threshold of THC could be 
achieved with THC concentration of 2.7 ng/mg and 4.5 ng/mg after the single and chronic 
smoking experiments, respectively. No accumulation of THC in blood or urine could be 
detected during the 10-day smoking period. A slight accumulation of THC-COOH in urine is 
possible, but could not be definitely confirmed.  
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Zusammenfassung 
 
Die Haaranalytik hat sich in der forensischen Toxikologie zunehmend etabliert. Vor allem im 
Bereich der Abstinenzkontrollen verdrängt die Haaranalytik die klassischen Matrizes Blut und 
Urin, aufgrund der vielen Vorteile, welche Haare im Vergleich bieten, allen voran das längere 
Nachweisfenster. Dennoch fehlt einiges an grundlegendem Wissen, was die Einflussfaktoren 
auf die Substanzkonzentrationen in den Haaren betrifft. Einer dieser Einflussfaktoren ist die 
Probennahmestelle am Kopf. Die Beschreibung dieses Faktors stellt das Thema dieser 
Dissertation dar. Dieses Thema wurde von Dussy et. al 2014 in einer kleinen Studie 
aufgegriffen. Die Studie hatte eine begrenzte Teilnehmerzahl von drei Personen und es 
wurden lediglich 10 Haarproben pro Kopf asserviert. Auch wurden nur Ethylglucuronid (EtG) 
und Koffein in der Studie untersucht und folglich konnten keine Aussagen bezüglich der 
Verteilung von z.B. Betäubungsmitteln gemacht werden.  
Um den Verteilungsmustern von Substanzen auf den Grund zu gehen, wurden in einem ersten 
Schritt die gesamten Kopfhaare eines einzelnen drogenabstinenten Probanden asserviert. Die 
Asservierung verlief in einem Rasterschema mit Gebieten von jeweils ca. 3x3 cm. Daraus 
resultierten insgesamt 104 Haarsträhnen, welche alle auf EtG und Koffein untersucht wurden. 
Die Untersuchung wurde mit einer selbst entwickelten Methode mittels LC-MS
3
, welche die 
zuvor eingesetzte GC-MS Methode ersetzte, durchgeführt. Die gefundenen EtG 
Konzentrationen lagen zwischen 6.8 pg/mg und 20.2 pg/mg, während die 
Koffeinkonzentrationen zwischen 1.1 ng/mg und 12.0 ng/mg lagen. Die Verteilungsmuster 
von EtG und Koffein unterschieden sich grundlegend. Koffein wies klar höhere 
Konzentrationen an der Peripherie der Frisur auf. Die höchsten Konzentrationen  wurden an 
der Stirn festgestellt. EtG wies hingegen kein klares Muster auf, ausser dass im Nacken 
deutlich tiefere Konzentrationen festgestellt wurden. 
Diese Resultate waren äusserst vielversprechend, weshalb daraufhin eine umfangreichere 
Untersuchung der Verteilungsmuster ins Auge gefasst wurde. Da in unserem Labor Kokain 
neben EtG am häufigsten in den Haaren festgestellt wird, wurden Alkohol- und 
Kokainkonsumenten für eine Studie rekrutiert. Von jedem Teilnehmer wurde die Gesamtheit 
der Kopfhaare asserviert und auf EtG, gängige Betäubungsmittel (DoA) und 
Benzodiazepinen/Z-Substanzen (BZD-Z) untersucht. Da von jedem Probanden um die 100 
Haarproben erwartet wurden, hätte der zeitliche Rahmen des Projektes eine Analyse auf alle 
benannten Substanzklassen mit den bestehenden Analysemethoden mit mehrfacher 
Probenaufarbeitung nicht zugelassen. Deswegen wurde eine kombinierte Probenaufarbeitung 
für alle drei Substanzklassen entwickelt. Die Methode basiert auf dem unterschiedlichen 
Retentionsverhalten der DoA und der BZD-Z gegenüber EtG auf einer Oasis Max® SPE 
Kartusche. Durch den Gebrauch der kombinierten Probeaufarbeitungsmethode konnte der 
Arbeitsaufwand massiv reduziert werden. Ausserdem war eine vollständige Analyse auch bei 
geringeren verfügbaren Probenmengen möglich. 
Zusätzlich zu der Beschreibung der Verteilungsmuster sollten die Gründe für die 
beobachteten Verteilungsmuster untersucht werden. Zusammen mit der Klinik für Angiologie 
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des Unispital Basel sowie dem Department für Sport, Bewegung und Gesundheit wurde eine 
Kooperation aufgebaut, um die Kopfhautdurchblutungsraten und Schweissraten auf dem Kopf 
zu untersuchen, da die Einlagerung über die Blutbahn und den Schweiss als wichtige 
Einlagerungsmechanismen gelten. Die Kopfhautdurchblutung wurde mittels "Laser Doppler 
Perfusion Imaging" untersucht. Jedes Haarprobennahmegebiet wurde so untersucht, um eine 
eins-zu-eins Korrelation der Perfusionsdaten mit den Konzentrationsdaten zu erlauben. Die 
Kopfschweissraten wurden gravimetrisch mit Hilfe einer Fahrradmütze untersucht. Diese 
wurde mit stark wasseradsorbierenden Pads ausgekleidet. Die Studienteilnehmer mussten 
10 Minuten ohne Mütze Fahrrad fahren und anschliessend weitere 10 Minuten mit der Mütze.  
Für diese Studie konnten 13 Teilnehmer rekrutiert werden, wovon 12 Kokainkonsumenten 
und 9 Alkoholkonsumenten waren. Die meisten Studienteilnehmer waren Konsumenten 
mehrerer DoA bzw. BZD-Z und somit konnten Verteilungsmuster von 29 verschiedenen 
Substanzen ermittelt werden. Die meisten Substanzen (beinahe alle DoA und BZD-Z) zeigten 
höhere Konzentrationen am Rande der Frisur. EtG hingegen zeigte oft ein gegensätzliches 
Verhalten mit höheren Konzentrationen im Vertexbereich. Es gab grosse interindividuelle und 
substanzspezifische Unterschiede im Ausmass der Verteilung. Zum Beispiel wies Kokain 
Faktoren zwischen 2.8 und 105 (Mittelwert 17.6) auf, wohingegen Methadon nur Faktoren 
zwischen 1.6 und 4.2 (Mittelwert 2.4) aufwies. Für EtG wurden Faktoren zwischen 2.5 und 
7.1 (Mittelwert 4.4) erhalten. Das Ausmass dieser Unterschiede ist durchaus relevant für die 
Bewertung von Haarproben. Typischerweise werden Grenzwerte bei der Bewertung von 
Haarproben angewendet. Unterschiede in dem gefundenen Ausmass können zu Situationen 
führen, in denen die Haarprobennahme von unterschiedlichen Kopfgebieten zu einer anderen 
Bewertung führt. Zum Beispiel werden für EtG die beiden Grenzwerte 7 pg/mg (5 pg/mg 
nach neuem SoHT Konsens 06.08.2019) für den Abstinenznachweis und 30 pg/mg, um 
zwischen sozialem Trinkverhalten und chronisch exzessivem Trinkverhalten zu 
unterscheiden, verwendet. In der Tat wies einer der 9 untersuchten Probanden EtG 
Konzentrationen zwischen 6.2 pg/mg und 30.4 pg/mg auf, womit die gefundenen 
Konzentrationen bei Verwendung des alten Grenzwertes den gesamten Interpretationsraum 
abdecken. Sieben der neun Studienteilnehmer wiesen Konzentrationen auf, welche zu mehr 
als einem Interpretationsbereich gehören. Dies ist natürlich problematisch und sollte während 
der Probenahme und der Interpretation der Ergebnisse berücksichtigt werden.  
Die Perfusionsmessungen zeigten kein klares Muster der Durchblutungsraten über den Kopf 
auf, obschon die Durchblutung im Nackenbereich tendenziell etwas tiefer war. Im Gegensatz 
dazu zeigten die Schweisssekretionsraten grosse Unterschiede über den Kopf. Die höchsten 
Schweissraten wurden an der Stirn gefunden, und generell an der Peripherie der Frisur. Die 
Schweissraten nahmen in Richtung Vertex ab. Somit zeigten die Schweissraten eine ähnliche 
Verteilung wie die Konzentrationen von vielen Substanzen, was vermuten lässt, dass die 
Konzentrationsunterschiede durch die unterschiedlichen Schweissraten verursacht werden 
könnten. Dabei würden die meisten Substanzen über den Schweiss eingelagert werden, mit 
Ausnahme von EtG, welches durch den Schweiss eher aus den Haaren rausgewaschen würde. 
Falls Unterschiede in den Schweissraten tatsächlich für die Konzentrationsunterschiede 
mitverantwortlich sind, müssen Substanzen einerseits von der Blutbahn in den Schweiss 
gelangen können und anschliessend vom Schweiss in das Haar gelangen und dort dauerhaft 
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eingelagert werden. Die meisten Studien, welche die Einlagerung von Substanzen aus 
Schweiss in die Haare untersuchen, tun dies im Kontext einer akuten externen Kontamination. 
Deswegen zielen die Studien meist auf das Kokain und verwenden meist sehr hohe 
Konzentrationen. Diese Konzentrationen sind unrealistisch in Bezug auf Situationen ohne 
externe Kontamination und mit dem Hintergrund der Ausscheidung dieser Substanzen durch 
den Schweiss. Aus diesem Grund wurde eine Studie zur Untersuchung der Einlagerung von 
Substanzen in die Haare aus einer synthetischen Schweisslösung mit realistischen 
Konzentrationen entworfen. Die Studie soll die Plausibilität der Hypothese, dass die 
Verteilungsmuster aufgrund von Unterschieden in den Schweissraten zustande kommen, 
testen. Diese Studie läuft zurzeit und es können noch keine definitiven Resultate präsentiert 
werden.  
 
Einer der Studienteilnehmer gab an, täglich Kratom zu konsumieren. Mitragynin und 7-
Hydroxymitragynin (7-Hy-Mitra) wurden in der Schweiz kürzlich in das 
Betäubungsmittelverzeichnis (BetmVV-EDI) aufgenommen. Vor diesem Hintergrund wurde 
eine Methode zum Nachweis von Mitragynin und 7-Hy-Mitra entwickelt und auf jede 
asservierte Haarsträhne dieses Konsumenten angewendet. 7-Hy-Mitra konnte in keiner seiner 
Haarproben nachgewiesen werden. Mitragynin zeigte eine enge Verteilung mit 
Konzentrationen zwischen 1.1 und 2.2 ng/mg ohne ein erkennbares Muster. Die Methode 
wurde auf einen Teil der Haare in der Routineanalytik angewendet, um die Prävalenz des 
Kratomkonsums in unserer Routinepopulation zu untersuchen. Von den 300 bislang 
gemessenen Haarproben wurde keine der Haarproben positiv auf Mitragynin getestet, was auf 
eine tiefe Prävalenz für wiederholten/regelmässigen Konsum schliessen lässt. 
 
Kürzlich wurde Cannabis mit einem THC Gehalt von unter 1 % und hohem Cannabidiol 
(CBD) Gehalt für den legalen Verkauf in der Schweiz freigegeben und ist nun z.B. an 
Kiosken erhältlich. Es bestand der dringende Bedarf zu überprüfen, ob das Rauchen von CBD 
Hanf zu Blut-THC-Konzentrationen über dem in der VRV Art. 2 Abs. 2 aufgeführten 
Grenzwert von 1.5 ng/ml (bzw. 2.2 ng/ml unter Berücksichtigung des Vertrauensintervalls), 
ab welchem die Fahrfähigkeit aufgrund eines nachgewiesenen THC-Konsums als von 
Gesetztes wegen als erwiesen gilt, führen könnte. Deswegen wurde ein Selbstexperiment mit 
dem Ziel durchgeführt, zu überprüfen, ob Blutkonzentrationen über dem Grenzwert erreicht 
werden könnten. Dazu rauchte eine Mitarbeiterin des IRM Basel einen CBD Joint. 
Währenddessen wurden in regelmässigen Abständen Blutproben entnommen. Ausserdem 
wurde für 24 Stunden jeder Spontanurin asserviert. Um zu überprüfen, ob eine Akkumulation 
von THC bei längerem CBD-Hanf Konsum wahrscheinlich ist, hat dieselbe Mitarbeiterin 
während 10 Tagen jeden Morgen und Abend jeweils einen Joint geraucht. Beim Rauchen des 
letzten Joints wurden analog zum ersten Experiment Blut- und Urinproben asserviert. Das 
Experiment zeigte, dass für eine kurze Zeit nach dem Rauchen Blutkonzentrationen über dem 
Grenzwert erreicht werden konnten. Die höchsten THC Blutkonzentrationen nach dem ersten 
und letzten Joint waren 2.7 ng/mg beziehungsweise 4.5 ng/mg. Es konnte keine 
Akkumulation von THC während der 10-tägigen Rauchphase festgestellt werden. Eine 
geringe THC-COOH Akkumulation im Urin der Mitarbeiterin könnte stattgefunden haben, 
die Resultate waren aber nicht hinreichend, um dies mit Sicherheit zu belegen. Solch eine 
Akkumulation könnte für den Abstinenznachweis mittels Urinproben problematisch sein. 
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1. Introduction 
 
1.1. An Overview – What Is Hair Analysis, What Is It Used for, and How Is 
It Done? 
Hair analysis has been steadily gaining footing in forensic toxicology as the matrix of choice 
for abstinence testing and for establishing a history of substance consumption.
1
 Hair is 
different from the classic matrices of choice, urine and blood, in that it has a much longer 
window of detection. While blood and urine usually cover time windows of a few hours or a 
few days, respectively, hair covers many weeks to months, allowing for a long retrospective 
view into the substance uptake history of a person. Hair offers many other advantages over 
blood and urine. Substances are stable in hair for long term storage if the hair is stored in a 
dry and dark environment. Hair does not need to be cooled or frozen for storage as urine and 
blood do, and a neatly packed hair lock takes very little storage space. Additionally, hair 
sampling is non-invasive compared to urine and blood sampling, and hair samples are much 
harder to adulterate than urine samples. These advantages make hair analysis very useful and 
promoted its application for purposes such as workplace drug testing, driver license regranting 
procedures, doping controls, for determining criminal liability and drug addictions in criminal 
cases, and child custody cases. While hair analysis has many advantages, it cannot be used to 
determine acute consumption or exposure to a substance. Also, the results of hair analysis 
cannot be used to judge the effects a substance had on a person at a specific time point. As 
useful as hair analysis is, it also suffers from numerous limitations, some of which will be 
discussed in chapter 1.6. For extensive reviews on hair analysis and its applications refer to 
Pragst and Balikova 2006, Kintz (Ed.) 2007, and Kintz, Salomone, and Vincenti (Eds.) 
2015.
2-4
 The first documented case of hair analysis dates back to 1858.
5
 The hair of a body 
that had been exhumed 11 years after death was analyzed and arsenic could be identified. 
More than a hundred years later in 1979 Baumgartner et al. published a paper describing the 
determination of the opiate abuse history from radioimmunological analysis of hair.
6
 This was 
the start of modern hair analysis. However, hair analysis really took off with the availability 
of GC-MS technology, allowing specific identification of substances as well as more sensitive 
analysis.  
Hair analysis typically proceeds via the following steps: First, hair is sampled. This is 
preferentially done at the vertex posterior of the head. Hair is sampled as close to the skin as 
possible by cutting a lock of hair using scissors. Afterwards, the hair is cut to a length 
corresponding to the desired time window (see chapter 1.3). The hair is washed to remove 
external contamination and after drying is cut into snippets for homogeneity and subsequently 
sometimes pulverized. In some reported methods, the hairs are dissolved using e.g. sodium 
hydroxide solutions to increase the extraction yields. The extracts are subjected to varying 
clean-up procedures such a solid phase extraction (SPE), liquid-liquid extraction, filtration, 
etc. The extracts are finally measured, typically using GC-MS
n
 or LC-MS
n
. These techniques 
are firmly established as the Gold Standard for hair analysis in forensic Toxicology.
7
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In the following chapters, hair structure, mechanisms of hair growth, skin anatomy, 
incorporation of substance into the hair, and pitfalls of hair analysis are briefly reviewed, and 
the topic of this thesis is introduced. 
1.2. Structure of Hair 
The structure of the human hair shaft, follicle anatomy, and the mechanism of melanin 
incorporation into the hair shaft are presented in Figure 1. The hair shaft is built up of three 
layers; the cuticle, the cortex, and the medulla.
8,9
 The cuticle is the outermost layer of the hair 
and consists of layers of cells with a structure resembling reptilian scales or shingles with the 
scale edges pointing towards the distal end of the hair shaft. Cuticle cells are typically about 
0.5 µm thick and have a visible length of about 50 µm. The cuticle has a thickness of about 5 
– 10 cuticle cells.8,10 The cuticle plays an important role in protecting the inner parts of the 
hair from environmental damage to the hair structure, while being responsible for keeping 
hair clean, disentangled, and is important for its shine.
2,8
 The cuticle is susceptible to damage 
from a variety of sources such as light, heat, or chemical treatment. With time, the protection 
provided by the cuticle may be compromised, and deeper hair layers can be exposed to the 
environment, leading to damaged and frayed hair towards the distal end.
11,12
 Below the cuticle 
is the cortex which makes up the large part of the hair. The cortex is responsible for giving the 
hair its color, structure and flexibility. Cortical cells are long spindle shaped structures that 
contain hard keratin filaments. A few hundred of these filaments together form larger 
structures called macrofibrils. Chemically, the hair is to a large part composed of alpha-
keratin intermediate filaments and keratin associated proteins, a group of proteins that form a 
cross-linked network between the filaments.
8,13
 Finally, in the center of the hair, is the 
medulla which is often absent or fragmented in human hairs. The medulla is made of a stream 
of cells that is interspersed with vacuoles. The number of medullar cells typically increases 
with increasing hair diameter.
9,10
 
Figure 1 Structure of the human hair shaft, anatomy of the hair follicle and mechanism of melanin integration 
into the hair shaft. Reprinted from Clinica Chimica Acta, 370, Pragst F., Balikova M.A., State of the art in hair 
analysis for detection of drug and alcohol abuse, 17-49, 2006, with permission from Elsevier. 
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The hair follicle is the structure from which the hair shaft emerges. The origin of cell 
proliferation, the hair bulb, is located at the bottom of the hair follicle, ca. 3-5 mm below the 
surface of the skin. The hair bulb encloses the follicular dermal papilla and a single capillary 
loop. At the bottom of the bulb, undifferentiated cells proliferate. The cells move upwards 
from this region into the suprabulbar region, grow in volume, and start to elongate vertically. 
The hair commences keratinization and fibrils are formed. At approximately one third of the 
way between the tip of the dermal papilla and the skin surface, the keratinization has 
completed. Above the suprabulbar region, is the bulge, which is the location where the erector 
pili muscle attaches to the hair follicle. The short region between the bulge and the entrance to 
the sebaceous gland is called the isthmus. The region between the sebaceous gland and the 
surface of skin is called the infundibulum. This funnel-shaped structure contains the hair 
shaft, sebum, and apocrine sweat, in the case of an associated apocrine sweat gland. 
Surrounding the growing hair shaft is the inner root sheath, which extends from the base of 
the bulb up to the isthmus. The cells of the inner root sheath are locked with the cuticle cells 
of the hair shaft to firmly hold it in place. The inner root sheath grows at the same speed as 
the hair and guides the hair shaft in its path. Surrounding the inner root sheath is the outer root 
sheath, which is believed to be source of stem cells critical for the development of the hair 
and is the attachment point of the erector pili muscle. In contrast to the inner root sheath, the 
outer root sheath may remain relatively stationary.
4,8,14
 
1.3. Hair Growth 
A large advantage of hair analysis is that substances are incorporated and fixed in the growing 
hair, allowing for the long window of detection. Additionally, as substances move with the 
growing hair, the hair stores a chronological consumption history.
15
 However, hair does not 
grow continually, but changes between phases of growth, rest, and finally removal with a new 
hair taking the place of the old hair. The hair growth phases are presented in Figure 2. The 
growing phase is called anagen phase and involves the construction of the hair matrix and the 
inner and outer root sheaths, the subsequent generation of the hair shaft, the pigmentation 
thereof, etc. In human scalp hair, the anagen phase has been reported to last about 1-6 years 
with about 80-90 % of hairs in this phase. After the anagen phase, the hair follicle is 
remodeled in the catagen phase. This involves among other things the involution of the lower 
hair follicle structures, club hair formation, and an upward movement of the dermal papilla. 
The duration of the catagen phase is not well described, but it is assumed to be quick and 
completed within a few weeks. Finally, the hair enters the telogen phase in which the hair 
stops growing and “rests”. The length of the telogen phase is variable with between 3-9 
months for human scalp hair. About 10-20 % of scalp hair is in the telogen phase at any time. 
Hair can be easily mechanically removed during this stage. Plucking a hair in the telogen 
phase immediately starts a new cycle of hair generation. The hair cycle is a hormone driven 
process with each hair follicle being in this cycle individually, meaning that there is a 
continuous exchange of hairs on the head at any given time.
2,4,9,16
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Figure 2 The phases of the human hair growth cycle. Reprinted from International Journal of Dermatology, 53, 
Buffoli, B. , Rinaldi, F. , Labanca, M. , Sorbellini, E. , Trink, A. , Guanziroli, E. , Rezzani, R. and Rodella, L. F., 
The human hair: from anatomy to physiology, 331-341, 2014, with permission from John Wiley and Sons Inc. 
 
The growth rate of hair plays a critical part in interpreting the results of a hair analysis. The 
SoHT recommends using a standard growth rate of 1 cm/month for interpretation of results.
17
 
The range of reported growth rates is quite variable however, with rates as slow as 
0.6 cm/month and as fast as 3.36 cm/month.
4,18
 The growth rates as well as the proportion of 
hairs in the anagen and telogen phase is dependent on many factors such as age, sex and 
hormone levels,
19
 ethnicity,
20-22
 state of health, season of the year,
23
 etc. This introduces a 
large degree of uncertainty into the chronological interpretation of a hair analysis. 
1.4. Skin Anatomy, Microcirculation, Sweat Glands, and Sebum Glands 
The skin is composed of three layers, namely the epidermis, the dermis, and the hypodermis 
or subcutaneous tissue, each of which will be described briefly. A schematic illustration of the 
skin anatomy is presented in Figure 3 (left). The epidermis is a thin layer of cells of around 
0.05-0.1 mm thickness mainly composed of keratinocytes. Also contained in this layer are 
melanocytes that distribute melanin to the surrounding keratinocytes. The dermis is a 
supporting matrix of between 0.5 mm and 5 mm thickness. The large part of the dermis is 
made of collagen which provides the skin with its tensile strength. The dermis also contains a 
number of other proteins and structures which provide the skin with e.g. elasticity and the 
ability to retain water. The dermis is strongly perfused through a system of vasculature layers 
as presented in Figure 3 (right). The layers are the superficial or subpapillary plexus located at 
the edge of the epidermis from which papillary loops rise, the dermal or middle plexus which 
supplies e.g. the hair follicle and sweat glands with blood, and the subdermal plexus located 
in the subcutaneous tissue.
24-26
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Figure 3 (left) Anatomy of the skin. Reprinted from Rook’s Textbook of Dermatology, MyGrath, J.A. and Uitto, 
J., Anatomy and Oragnization of human Skin, 2008, with permission from John Wiley and Sons Inc (right) 
Illustration of the skin vascular plexuses. Reprinted from Journal of Anatomy, Imanishi, N., Kishi, K., Chang, 
H., Nakajima, H., & Aiso, S., Three-dimensional venous anatomy of the dermis observed using stereography, 
2008, with permission from John Wiley and Sons Inc 
 
Humans have eccrine and apocrine sweat glands. Eccrine sweat glands are located over 
almost the entire body including the scalp. Sweat is considered an important possible 
mechanism for the incorporation of substances into the hair.
2
 An eccrine sweat gland is 
composed of a secretory coil located in the lower dermis and a duct which leads upwards and 
opens onto the skin surface. Eccrine sweat glands play an important part in the 
thermoregulation of the body. When sweat glands are activated, they pump NaCl into the 
secretory coil. This causes an influx of water into the coil as it now has a higher osmolality 
than the surrounding cells. This causes hydrostatic pressure to increase and results in the 
sweat gland pumping out water with maximum rates approaching 20 nL/min/gland. In the 
upper parts of the sweat duct, NaCl is actively transported back into the surrounding cells to 
limit the salt loss of the body.
27
 Apart from eccrine sweat glands, apocrine glands can also be 
found in human skin in the genital, axillary and mammary areas. In contrast to eccrine glands, 
apocrine glands are directly connected with a hair follicle and sweating follows a different 
secretion mechanism. In apocrine glands, the secretion is accomplished by pinching off parts 
of the cells. The secretion is rich in lipids and plays no role in thermoregulation.
24
  
Sebaceous glands are a further secretory unit of the skin. They are found all over the body 
with most being associated with hair follicles. They open into the upper part of the hair 
follicle above the bulge and are the upper border of the isthmus. Sebaceous glands consist of 
one or more lobules, each with a duct going to the main sebaceous duct which then goes 
further to the follicle. Sebaceous glands produce sebum via the holocrine rupture of sebocytes. 
The main components of the excreted sebum are triglycerides, wax ester, squalene, and free 
fatty acids.
28
 The time for sebum to reach the skin surface was measured using injection of 
radiolabeled acetate into the forehead of four volunteers. Maximum radioactivity was 
measured eight days after injection.
29
 Sebum is considered a further possible pathway for 
substance incorporation into the hair. 
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1.5. Incorporation of Substances into the Hair 
The mechanisms of substance incorporation into hair are not fully understood. Three main 
routes of incorporation are usually discussed; incorporation into the growing hair via the 
bloodstream, incorporation via sweat or sebum, and incorporation from external sources as 
presented in Figure 4.
3,30,31
 Incorporation via the bloodstream has typically been seen as the 
most important pathway and also the pathway with most interpretive value. Even for 
incorporation via the bloodstream, there seem to be different mechanisms, depending on the 
physicochemical characteristics of the substance. An analysis of the entire hair including the 
root in 1 mm segments 10 hours after a single zolpidem use, revealed that zolpidem is 
incorporated primarily at the bulb.
32
 However, a second much smaller peak was found in the 
2-3 mm segment, approximately corresponding to the region where sebum enters the hair 
follicle. In contrast, a study investigating the incorporation of EtG found that in beard hair 
EtG is primarily incorporated into the upper part of the hair root, instead of the bulb.
33
 These 
results indicate that the highly lipophilic Zolpidem is incorporated differently to the highly 
hydrophilic EtG. A follow up study revealed that the incorporation of zolpidem is 
fundamentally different for colored hair than for white hair, as in white hair the peak 
corresponding to incorporation via the bulb was missing and only the second, smaller peak 
was detected.
34
 An increased incorporation of basic drugs with increasing melanin content in 
the hair had been previously described by many researchers,
35-39
 and has led to questions 
about racial bias in hair testing.
37,40,41
 The incorporation of substances from the blood stream 
into the hair is assumed to be mainly affected by the lipophilicity and basicity of the 
substance.
42
 Lipophilic drugs can enter the matrix cells of the growing hair follicle by 
penetrating through the cell membranes. The penetration of the membranes is only readily 
possible for uncharged species. The ionized species of acidic and basic substances are not able 
to pass though cell membranes. Therefore, the equilibrium concentrations between the sides 
of the membrane will be dependent on the pH on those sides. Keratinocytes and melanocytes 
have a lower pH than blood plasma.
43
 Therefore, basic substances will tend to accumulate in 
hair. Metabolism of substances usually leads to more hydrophilic metabolites, as these are 
more readily excreted via urine. Due to the higher hydrophilicity, the metabolites might be 
incorporated into the hair to a lesser extent. This is one explanation for the observation that 
the metabolite concentrations in hair are frequently lower than what would be expected from 
the plasma area under the curve concentrations as compared to the parent substances.  
Incorporation via sweat and sebum presents a problem for the interpretation of hair results. If 
substances incorporate into the hair via sweat, the chronological information of the hair may 
be obfuscated, as sweat can act on the entire length of the hair strand. Additionally, sweat and 
sebum could be transferred to the hair of a non-consumer and yield false positive results. 
Substances are excreted into the sweat as is demonstrated by many studies using sweat pads 
for abstinence testing.
44-58
 There are few studies on the concentrations of substances in sweat 
and whether theses concentrations can lead to incorporation of relevant levels into the hair. 
Incorporation of substances from external sources such as powders or smoke presents a 
further source of false positive results.  
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1.6. Limitations and Pitfalls in Hair Analysis 
While hair as a matrix offers unique possibilities in the context of forensic work, especially 
the long window of detection, it also suffers from several limitations and possible pitfalls. 
Some of the most important pitfalls are discussed in the following sections. These pitfalls are 
also areas of much research and represent trends in the focus of hair analysis. New, more 
sensitive, methods and instruments are being employed in research to address these problems.  
Hair analysis generally suffers from a poor correlation between the consumed amount of a 
substance and the concentrations measured in the hair. Therefore, it is not possible to 
determine the consumed amount of a substance from the hair concentrations. At most, a rough 
estimate of the consumed amount is possible and even this should be done with much caution. 
The underlying cause of this poor predictive value of hair results is likely the poor 
understanding of the exact incorporation mechanisms of substances into the hair and the 
contributions of the many individual factors (e.g. sex, age, BMI, genetic polymorphisms, hair 
color, hygienic habits, consumption style, environmental influences, hair thickness and length, 
etc.). Because of the difficulty in interpreting hair concentrations, many laboratories only 
categorize the concentrations roughly as e.g. low, mid, and high concentrations as compared 
with the result collective of this laboratory.  
1.6.1. Variable Growth Rates and Sampling Error 
One benefit of hair analysis is a chronological history of consumption starting with the 
present at the hair root and extending back roughly one month for every centimeter of hair. 
Unfortunately, the rate of hair growth varies for different people and even for hairs of the 
same person. A consequence of this is that the actual time period reflected by a hair sample is 
in the individual case usually unknown and is at best a rough estimate. Furthermore, sampling 
Figure 4 Proposed incorporation pathways of 
substances into the growing hair strand. Reprinted from 
Clinica Chimica Acta, 370, Pragst F., Balikova M.A., 
State of the art in hair analysis for detection of drug and 
alcohol abuse, 17-49, 2006, with permission from 
Elsevier 
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hair strands is quite difficult and remaining stubbles on the head or unequal length of 
remaining hairs can cause additional errors.
59
 
1.6.2. Growth Cycle, Catagen and Telogen Hair 
As described above, hair grows in cycles with about 10 to 20 % of total head hair in the 
telogen phase. As these hairs do not grow, they do not reflect the same time period as the 
growing hairs around them. The longer the hair is in the telogen phase, the larger the 
discrepancy between this hair and the surrounding, growing hairs becomes.
59
 This, together 
with variable growth rates of individual hair strands, causes a blurring of the chronological 
consumption history of the hair. If a person enters an abstinence after a time period of 
excessive consumption, the non-growing telogen hairs can cause hair testing to be positive in 
hair sample lengths that should reflect the abstinence period.
60
  
1.6.3. Washout Effects 
Washout effects describe the removal of incorporated substances from the hair. This can be 
e.g. from UV light, from shampooing and washing the hair, from exposure to chlorinated or 
ozonated water in e.g. swimming pools, or from cosmetic treatments.
11,12,61-75
 Because of the 
washout effect the SoHT recommends alcohol abstinence testing in hairs of maximally 6 cm 
length.
76
 Many studies have investigated washout effects both in vitro and for some case 
studies in vivo. The results are often contradictory regarding the extent or even presence of 
washout effects, suggesting that washout effect may be dependent on the type of substance 
and on the individual. Especially in the early days of hair analysis, many different 
methodologies for hair washing and extraction were employed. This could affect the 
reproducibility and transferability of the results of these studies.  
1.6.4. External Contamination 
One of the major issues that hair analysis is confronted with is the possibility of external 
contamination of the hair. In this context, external contamination describes the incorporation 
into the hair or adherence of substances onto the hair from external sources such as powder or 
smoke. External contamination can lead to a person being tested positive for a substance even 
though this person did not consume this substance.
77,78
 This can be a problem for people who 
work in an environment where drug consumption is frequent such as clubs or bars, for drug 
enforcements officers,
79-81
 or for interpreting the results from children living in an 
environment where drugs are being consumed.
82-84
 Many different washing procedures have 
been proposed to deal with external contamination,
85-89
 but a recent study from Cuypers et al. 
has shown that the washing procedures themselves can cause irreversible incorporation of 
external substances into the hair.
90
 A different strategy for dealing with external 
contamination is to use metabolites to differentiate between exposure and consumption when 
a metabolite is available.
91-96
 This strategy, while often successful, is faced with problems 
such as metabolites being present in the drug material or low concentrations in the hair 
making the analysis difficult.  
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1.7. The Distribution of Substances in Hair over the Scalp 
A question which has so far not been addressed in this discussion, and represents the 
overarching topic of this thesis, is whether the location of hair sampling on the scalp, 
influences the concentration of substances in the hair. Numerous studies have looked at hair 
from different body sites and compared it to scalp hair,
97-100
 but there had been only one 
previous publication by Dussy et al. specifically looking at differences in scalp hair depending 
on sampling site.
101
 In this publication, Dussy showed for EtG and caffeine for three persons 
and for ten locations on the head that the location of hair sampling influences the 
concentrations with coefficients of variations between 14 – 28 % and 13 – 62 % for EtG and 
caffeine, respectively. However, the ten sampling locations on the head were not exactly 
defined and did not show a picture of the entire scalp. Therefore, statements concerning the 
pattern of distribution and explanations thereof were not possible from this data. Additionally, 
while EtG is one of the most important parameters in hair analysis, no investigation on drugs 
of abuse (DoA) was conducted. Finally, a sample size of three people is not enough for 
making general statements on the distribution patterns.  
In general, hair samples are taken from the vertex posterior region of the scalp as 
recommended by the Society of Hair Testing (SoHT)
102
 and the European Workplace Drug 
Testing Society (EWDTS),
103
 as hair from this region has been reported to have the largest 
percentage of hair in the anagen phase and the highest hair growth rate.
9
 Additionally, from a 
practical view, sampling from the vertex posterior is often easier and has a lesser impact on 
the haircut of the tested person. However, hair is often sampled from regions other than the 
vertex for reasons such as insufficient hair length at the vertex, male pattern baldness, 
cosmetic aspects, contamination at the vertex, etc. The SoHT proposed cut-off values are 
defined based on values obtained from the measurement of hair samples from the vertex 
posterior and should therefore strictly speaking not be applied to hair from other regions. 
Additionally, concentration differences in hair strands depending on the sampled region can 
be problematic, as it is common practice to sample two hair strands; one for the analysis and 
another for confirmation reanalysis in case of any doubts. If the strands are taken from 
different areas of the head, concentration differences can be expected, leading to ambiguous 
results that can cause problems when applying the SoHT cut-offs. Therefore, there is an 
urgent need to characterize the regional differences in scalp hair concentrations for at least the 
most prevalent substances EtG, common DoA and the benzodiazepines/z-substances (BZD-
Z). As the mechanisms of incorporation of substances into the hair are poorly understood, it 
was also important to investigate the cause of the observed differences.  
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2. Goals and Approach 
 
The overarching goal of the project was to characterize the shape and extent of distribution of 
substances in scalp hair over the entire head. From the previously mentioned study by Dussy 
et al. 2014, it was hypothesized that the location of sampling plays a significant role. Also, 
based on the differences obtained for caffeine and EtG by Dussy et al. 2014, it was 
hypothesized that the nature of the substance could influence the shape and extent of the 
distribution. The focus was placed on the most important substances for routine work at our 
lab; EtG, the common DoA (except THC), and the BZD-Z. Another goal was to find 
explanations for the suspected differences across the scalp. To approach this topic, four 
projects were or are currently being conducted. 
Project 1 – Single-Person Distribution Study: As there was little previous information on the 
distribution patterns, the first goal was to confirm the findings of Dussy et al. 2014 while 
expanding on their work. For this, the distribution patterns of EtG and caffeine over the scalp 
of a single person were fully characterized. The entire scalp hair of the test subject was 
divided into strands of around 3x3 cm size and sampled individually, yielding around 100 
strands. First and foremost, this was a pilot study to ascertain if it was worth it to keep 
investigating in this direction and to gain information for the planning of a more 
comprehensive study.  
Project 2 – Combined Sample Preparation Method: As the results of the first study were very 
promising, the investigation of the distribution patterns was continued. The aim was to look at 
all the aforementioned relevant substances with a larger group of test subjects. From 
conducting the first project, it was apparent that the analytical workload would be 
overwhelming if thousands of hair strands were to be investigated for all of these substances. 
Therefore, a combined hair sample preparation method for EtG, DoA and BZD-Z was 
developed for subsequent measurement with LC-MS
3
/MRM. The approach of the combined 
sample preparation was the separation of EtG from the DoA and BZD-Z by using their 
different retention characteristics on an Oasis Max SPE cartridge. While still requiring three 
injections to measure all parameters, the combined sample preparation could greatly reduce 
sample preparation time and the required amount of hair for a full analysis. 
Project 3 – Distribution Patterns of EtG, DoA and BZD-Z: A study on a larger scale was 
planned to expand the sample size and to include cocaine, which is the most prevalent DoA 
beside THC in our routine population. For this, alcohol and cocaine consuming persons were 
enlisted and the same hair sampling as in project 1 was done. In addition to the description of 
the distribution patterns, possible causes for the observed differences were investigated. For 
this, in cooperation with the clinic for angiology at the University Hospital Basel and with the 
department of Sport, Exercise and Health of the University of Basel the differences in head 
skin perfusion and the head skin sweating rates across the scalp were investigated. A laser 
Doppler anemometer was used to investigate the head skin perfusion. The sweating rates were 
measured gravimetrically using a cycling cap lined with water absorbing pads. 
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Project 4 – Substance Incorporation via Sweat: From the results of project three, we suspected 
differences in sweating to be a major source of the concentration differences across the scalp. 
For sweat to be a major incorporation pathway, substances must be able to cross from the 
bloodstream into the sweat and then be able to go from the sweat into the hair. Most research 
studying the incorporation of substances from the sweat into the hair were conducted within 
the context of external contamination. Therefore, these studies usually focused on cocaine and 
employed high concentrations and unrealistic conditions for modeling the daily incorporation 
via sweat of a drug user. On this basis, the incorporation of our routine panel of substances 
into the hair from artificial sweat solutions was investigated to test the plausibility of our 
hypothesis that sweat is a major contributor to the concentration differences found across the 
head.  
Project Kratom – Mitragynine and 7-Hydroxymitragynine in Hair: A study participant of 
project 3 declared that he consumes 3g of kratom each day. Mitragynine and 7-Hy-Mitra have 
recently been added to the list of scheduled substances in Switzerland. A literature search 
revealed no published hair concentration values or analytical methods for the major kratom 
alkaloid mitragynine or for the minor alkaloid 7-Hy-Mitra. Therefore, an analytical method 
for the quantification of mitragynine and 7-Hy-Mitra was developed and applied to all hair 
samples of the study participant. Additionally, the method was applied to every subsequently 
measured routine hair sample analyzed for DoA to estimate the prevalence of Kratom 
consumption in our routine population.  
Project CBD – Cannabinoids in Blood and Urine after Smoking CBD Joints: Recently, hemp 
material containing less than 1 % THC and high amounts of CBD have become available for 
legal purchase in Switzerland. This material is sold with many declared purposes e.g. as 
tobacco replacement, as food stuffs, in cosmetics, or for vaping. Confectioned CBD cigarettes 
can already be bought at the supermarkets or kiosks in Switzerland. No information was 
available if smoking this CBD rich hemp could yield THC concentrations above the legal cut-
off concentration of 1.5 ng/mL in blood (VRV Art2. Abs.2, 2.2 ng/mL with the confidence 
interval). Therefore, a self-experiment was conducted to determine if concentrations above 
this legal limit were reached. In this experiment, an employee of the institute smoked a CBD 
joint while blood was collected at regular intervals. Urine was collected from every 
spontaneous void. To see if an accumulation of THC could occur, the same person smoked 
two CBD joints per day for ten days. While smoking the last joint, blood and urine were again 
collected.  
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3. Publications 
 
3.1. Project 1: Distribution Pattern of Ethyl Glucuronide and Caffeine 
Concentrations over the Scalp of a Single Person in a Forensic Context 
 
About Project 1 
This publication describes the first thorough investigation of the distribution patterns of EtG 
and caffeine in hair across the head. Large concentration differences were found and for 
caffeine a clear concentrations pattern was observed.  
 
Authors: Ulf Meier, Thomas Briellmann, Eva Scheurer, Franz Dussy 
 
Contributions of Ulf Meier: 
 Involved in planning the study 
 Method development for analysis 
 Conducting the sample preparation, measurements and data evaluation 
 Writing the article 
 
CRediT Statement: 
Ulf Meier:  Conceptualization, formal analysis, investigation, methodology, project 
administration, visualization, writing – original draft 
Thomas Briellmann:  Conceptualization, writing – review & editing 
Eva Scheurer:  Supervision, writing – review & editing 
Franz Dussy:   Conceptualization, supervision, writing – review & editing  
 
 
 
Status: Published 
 
Copyright © 2017 John Wiley & Sons, Ltd 
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3.2. Project 2: Sample Preparation Method for the Combined Extraction of 
Ethyl Glucuronide and Drugs of Abuse in Hair 
 
About Project 2 
This publication describes a combined hair sample preparation method for EtG and DoA for 
subsequent analysis using LC-MS
3
/MS
2
. This method allows substantially reducing the 
workload when analyzing samples for both these parameter groups while reducing the amount 
of required hair. 
 
Authors: Ulf Meier, Thomas Briellmann, Eva Scheurer, Franz Dussy 
 
Contributions of Ulf Meier: 
 Development of the combined sample preparation method 
 Conducting the sample preparation, measurements and data evaluation 
 Writing the article 
 
CRediT Statement: 
Ulf Meier:  Conceptualization, formal analysis, investigation, methodology, project 
administration, writing – original draft 
Thomas Briellmann:  Writing – review & editing 
Eva Scheurer:  Supervision, writing – review & editing 
Franz Dussy:   Conceptualization, supervision, writing – review & editing  
 
 
 
Status: Published 
 
Copyright © 2017 John Wiley & Sons, Ltd 
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3.3. Project 3: Distribution Pattern of Common Drugs of Abuse, Ethyl 
Glucuronide, and Benzodiazepines in Hair Across the Scalp 
 
About Project 3 
This publication describes a thorough investigation of the concentration distribution patterns 
of EtG, DoA, and BZD-Z across the head for a collective of 14 persons. Additionally, the 
publication describes the measurement of the head skin perfusion and sweating rates across 
the scalp and compares them to the concentration distributions.  
 
Authors: Ulf Meier, Flora College, Stephan Imfeld, Thomas Briellmann, Katja Mercer-
Chalmers-Bender, Eva Scheurer, Franz Dussy 
Contributions of Ulf Meier: 
 Planning the study 
 Writing all documents required for ethics committee 
 Managing recruitment including writing/designing recruitment materials and 
distribution of materials 
 Project management of the study including establishing collaboration with partners 
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3.4. Project 4: Incorporation of Forensically Relevant Substances into 
Hair via Exposure to Spiked Artificial Sweat Solutions 
 
About Project 4 
The aim of this project is to test the plausibility of the hypothesis set up in project 3 that the 
distribution patterns are caused by different sweat rates across the head. For the sweat rates to 
influence the concentrations found in hair samples, substances must be able to enter the hair 
via the sweat. This is being examined in this project. The project is currently underway, and 
no definite results are available yet. The project is presented in detail in the following. The 
results will be submitted to Drug Testing and Analysis. 
 
Authors: Ulf Meier, Eva Scheurer, Franz Dussy  
 
Contributions of Ulf Meier: 
 Planning the study 
 Doing the lab work 
 Evaluating the results 
 Writing the article 
 
 
 
Status: Experiments in progress 
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3.4.1. Motivation for Project 4 
 
In project 3, large concentration differences depending on sampling location on the head were 
identified. The sweating rates across the head showed a similar distribution as the 
concentrations. For sweat to cause the observed distribution patterns, substances must be able 
to enter the sweat from the bloodstream and be able to enter the hair from the sweat. The 
ability of substances to enter the hair via diffusion from the sweat is investigated in this 
project.  
 
A number of studies have investigated the incorporation of substances into the hair from 
external sources in the context of contamination from e.g. cocaine powder.
11,77,85-87,104,105
 
These studies suffer from several limitations if the results are to be applied to the research 
question of this project. In some studies (e.g. Stout et al. 2006 and Ropero-Miller et al. 2012), 
cocaine was applied to the hair as a powder. While care was taken to apply the powder in a 
uniform way (e.g. by applying a defined amount of cocaine to gloved hands and subsequently 
rubbing the hair in the hands for a defined time), the actual amount of cocaine applied to the 
hair is unknown. Afterwards, different solutions such as artificial sweat solutions were 
applied to the hair to allow diffusion of the applied cocaine powder into the hair. This is likely 
a realistic model of external contamination from powder, but not very realistic regarding 
incorporation from sweat of a cocaine consuming person. In other studies, such as the studies 
of Schaffer et al. 2005 and Gerace et al. 2017, hair was subjected to cocaine solutions for 
prolonged periods. For example, Schaffer et al. soaked hair in a solution containing 1, 10, or 
50 ng/µL cocaine for one hour,
86
 and Cairns et al. 2004 also soaked hair in a 1 ng/µL solution 
for one hour.
85
  For a model of incorporation via sweat, this is not a realistic model. Sweat on 
the hair dries fairly quickly and based on what little information is available from sweat patch 
experiments,
47,50,52,53,55,58
 depending on the consumed amount, concentrations are likely lower 
than in these soaking experiments. Additionally, while the hair will be wet for only a short 
period of time, a regular cocaine consumer will expose their hair to cocaine containing sweat 
many times. Finally, the described studies investigated only cocaine or cocaine metabolites 
and only few studies investigate the incorporation of other substances such as opioids/opiates 
into the hair. Therefore, there is a need for a study investigating the extent of incorporation 
into hair from sweat with a realistic model of exposure and for an array of forensically 
interesting substances.  
 
This study attempts to manage the mentioned limitations of previous studies by using a more 
realistic contamination model regarding concentrations, exposure style, exposure duration, 
exposure frequency, and including normal hygienic routine steps. The aim of this study is to 
test the plausibility of sweat rate differences across the head being the cause of the 
concentration differences that were observed across the head in the previous studies and 
further to test whether differing ability of the substances to enter the hair can explain the 
differences in the extent of the observed distribution patterns. This study is currently still 
underway. As such, the number of participants, exact methodology, interpretations, etc. are all 
subject to change before publication of the study. Some preliminary results are presented at 
the end of this section. 
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3.4.2. Materials and Methods  
 
3.4.2.1. Study Design 
Hair was collected from alcohol, DoA, and BZD-Z non-consuming acquaintances or 
employees of our institute after getting their hair cut. As such, the distal end of the hair was 
collected. The single hairs were manually formed into hair locks. One side of the 
manufactured hair locks was glued together using hot glue to fix the lock and prevent hair loss 
during soaking and cleaning steps. Hair locks were cut to a length of 3.5 cm from the glued 
segment. Hair locks were made so that before gluing the weight of the hair was approximately 
40 mg.  
Hair locks will be subjected to varying numbers of exposures to contaminated sweat 
solutions, cleaning steps, and exposures to a clean sweat solution. This is done to mimic a 
single consumption of substances or regular consumption of substances for different time 
periods. Hair samples will be soaked in sweat solutions with concentration levels low (EtG 
0.05 ng/µl, DoA/BZD-Z 0.01 ng/µl), mid (EtG 0.1 ng/µl, DoA/BZD-Z 0.1 ng/µl), or high 
(EtG 0.2 ng/µl, DoA/BZD-Z 1.0 ng/µl). Hair soaking will be done as follows: A hair strand is 
placed into a 4 ml vial containing the spiked sweat solution for 10 seconds while gently 
moving the hair strand to ensure full wetting. The lock is removed from the bath while gently 
pulling along the edge of the vial to remove excess solution. The lock is placed on a paper 
towel and allowed to fully dry at room temperature as determined by inspection before 
repeating the soaking process. After every second soak, the hair lock is washed to simulate 
normal hair hygiene. Hair washing is done by rinsing the hair under running water for 20 
seconds. Afterwards, 50 µl of shampoo is applied to the hair, rubbed in, and allowed to act on 
the hair for 1 minute. The hair is rinsed under running water for 30 seconds, placed on a paper 
towel, and allowed to dry. After complete drying, 30 µl of an artificial sebum-sweat emulsion 
is applied to the hair to restore the removed fat. This soaking-cleaning process is repeated 
until hair locks have been soaked for 1 time, 7 times, 28 times, or 56 times. For the 1-time and 
7-times treatments, an extra lock is treated for each concentration level. For the extra lock, 
soaking and washing steps will be continued using a “clean” sweat solution containing no 
EtG, DoA, or BZD-Z until 28 soaks have been done. This is done to simulate a single or 
short-term consumption period, followed by a period of abstinence. After the hair has been 
soaked for their respective times, the glued section of the hair will be cut off and discarded.  
 
3.4.2.2. Materials and Instrumentation 
For all reference materials, internal standards, solvents, and instrumentation see sections 3.2 
and 3.3. The artificial eccrine perspiration (pH 4.5, stabilized) and the artificial eccrine sweat-
sebum emulsion (pH 4.5, not stabilized) were purchased from Pickering Laboratories Inc. 
(Mountain View, CA, USA).  
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3.4.2.3. Sample Preparation and LC-MS/MS Analysis 
The locks will be washed for 3 minutes with 4 ml water and twice with 4 ml acetone. Each 
wash solution will be individually collected for analysis. Hair locks will be prepared and 
analyzed according to the combined sample preparation method (see sections 3.2 and 3.3). 
For all validation parameters see sections 3.2 and 3.3. Wash solutions will be analyzed as 
follows: The wash solutions will be spiked with internal standard mix. The acetone washes 
will be dried under nitrogen and resuspended in 1.5 mL water:MeOH 1:1. The water wash 
solutions and the resuspended acetone wash solutions will be added to an Oasis Max SPE 
column and prepared and analyzed with the combined sample preparation method. The 
concentrations in the wash solutions are normalized to the amount of washed hair. The 
concentration of the wash solutions is normalized to the hair amount as pg substance/mg washed 
hair. 
3.4.3. Pre-experiment and Preliminary Results 
As this is still work in progress no definite results can be presented yet. A pre-experiment has 
been conducted to test if the practical handling works and if sensible concentration levels 
were chosen. The pre-experiment will be briefly presented here. The three concentration 
levels low (EtG 0.01 ng/µl, DoA/BZD-Z 0.01 ng/µl), mid (EtG 0.1 ng/µl, DoA/BZD-Z 0.1 
ng/µl), and high (EtG 0.2 ng/µl, DoA/BZD-Z 1.0 ng/µl) were chosen. Locks were soaked in 
the respective solution for 10 seconds. Afterwards, the hair locks were allowed to dry on a 
paper towel. After two rounds of soaking, the locks were washed as described above 
including the shampooing, but not including the application of the sebum-sweat emulsion. 
Locks were soaked in the spiked sweat solutions a total of 10 times. After the final soak the 
locks were washed with shampoo. The hair samples were then prepared and analyzed as 
described above, including analyzing the wash solutions. The experiment was conducted in 
triplicate. The results of the pre-experiment are presented in Table 1 and Table 2. The analysis 
of the wash solutions has not been validated. Values for the wash solutions are reported for 
samples with S/N ratios ≥ 10.    
The substance concentrations in the hair locks seem to increase proportionally to the 
concentration in the sweat. For EtG, the low concentration did not yield measurable results. 
Therefore, the EtG concentration in the low level is increased 5-fold from 0.01 ng/µl in the 
pre-experiment to 0.05 ng/µl in the experimental plan. For the DoA, the low concentration 
yielded results that were generally below the LOQ/LOD, the mid concentration yielded results 
generally below the proposed abstinence cut-off for many of the substances by the SoHT of 
200 pg/mg (range 24 pg/mg [BE] up to 213 pg/mg [MDA]), and the high concentration 
yielded results up to around 1500 pg/mg (range: 227 pg/mg [BE] to 1575 pg/mg [MDA]). The 
concentrations of the BZD-Z were generally higher than for EtG or DoA and ranged from 
non-detectable (zopiclone) to 35 pg/mg (oxazepam/bromazepam) for the low concentration, 
from 38 pg/mg (zopiclone) to 360 pg/mg (oxazepam) for the mid concentration, and from 
420 pg/mg (zopiclone) to 3660 pg/mg (diazepam) for the high concentration level. The 
concentrations were quite substance dependent. EtG clearly showed the lowest incorporation. 
Of the DoA, benzoylecgonine showed the lowest incorporation while methadone on average 
showed the highest. This may be because benzoylecgonine is amphoteric in contrast to the 
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otherwise basic DoA. The BZD-Z generally showed a higher degree of incorporation than the 
DoA or EtG. Among the BZD-Z, zopiclone showed a much lower incorporation than the 
other substances, which may be due to its weak basicity compared to the other BZD-Z. The 
second acetone wash solution typically contained only relatively low concentrations of EtG 
and DoA, no higher than 15 % of the concentration in the hair, except for MTD and EDDP. 
This is in contrast with the BZD-Z, for which the second acetone washing step still contained 
about 30 % to 60 % of the concentrations found in the hair. The applied washing procedure 
was chosen as it follows the harmonized hair washing/decontamination procedure currently 
being discussed in Switzerland.  
 
The results show that after soaking hair locks ten times in spiked sweat solutions, relevant 
concentrations of EtG, DoA, and BZD-Z were found in or on the surface of the hair and the 
“contamination” could not be fully removed by our washing procedure. These preliminary 
results at least do not contradict our working hypothesis that the distribution patterns observed 
in projects 1 and 3 are caused by differences in sweating rates. However, they do not explain 
the observed extent of the distribution patterns. For example, cocaine generally showed high 
differences across the head while methadone showed low differences. The preliminary results 
show that methadone seems to be incorporated better into the hair via sweat than cocaine. 
This is the opposite behavior than what would be expected if the ability of substances to enter 
the hair via the sweat is the determining factor for the extent of the distribution patterns across 
the head. This suggests that the extent of the distribution patterns is not determined by the 
propensity of substances to enter the hair from the sweat and is more likely determined by the 
ability of the substances to enter the sweat from the blood. The results will also be relevant for 
routine forensic hair interpretation. From the preliminary results it is likely that they will show 
that all tested substances have the ability to enter the hair and can be incorporated strongly 
enough to not be removed by the applied standard washing procedure. This is problematic for 
interpretation of results as it opens up the possibility of transfer of substances of a consumer 
to a non-consumer via sweat, including transfer of drug metabolites.    
As these results are only preliminary they should be interpreted cautiously and a more 
thorough discussion will be held when definite results are available. Additionally, no reliable 
data on the concentrations of the substances in the sweat in relationship to blood 
concentrations are available. This should be the focus of future studies. 
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Table 1 EtG and DoA concentrations in hair locks soaked 10 times in sweat solutions spiked with low, mid or high concentrations. Normalized concentrations of 
EtG and DoA in the water, first acetone, and second acetone wash solutions. (*) Approximate value as below LOQ. Concentrations are given as pg/mg.  
Sample EtG Coc BE NorCoc CE Mor MAM Codeine AcCo MTD EDDP Amph Meth MDMA MDA Ritalin 
Hair-Low-1 - - - 11 19 - - 6* 9 19* 15 11 8* 10* - - 
Hair-Low-2 - - - 10 14 - - - 8 19* 14 18 5* 16* - - 
Hair-Low-3 - - - 8 14 - - 5* 6 13* 11 9 6* 10* - - 
Hair-Mid-1 7.8 76 28 121 107 66 70 55 97 204 142 90 71 113 121 61 
Hair-Mid-2 8.7 85 32 126 110 63 62 49 89 178 114 165 127 189 213 77 
Hair-Mid-3 8.1 55 24 78 67 37 39 33 52 116 73 88 68 104 113 46 
Hair-High-1 16.8 620 298 933 746 512 545 420 694 1460 1002 865 679 1065 1027 510 
Hair-High-2 16.7 652 282 1057 771 514 469 395 650 1463 928 1328 1053 1517 1575 572 
Hair-High-3 16.4 490 227 802 604 435 425 340 577 1192 771 854 679 965 1052 439 
H2O-Low-1 - - - - - - - - - - - - - - - - 
H2O-Low-2 - - - - - - - - - - - - - - - - 
H2O-Low-3 - - - - - - - - - - - - - - - - 
H2O-Mid-1 5.6 - - 23 23 20 19 - 22 19 19 22 18 22 22 15 
H2O-Mid-2 2.3 - - 14 16 11 - - - 15 14 22 18 18 28 9 
H2O-Mid-3 2.1 - - 12 12 8 8 - - 13 11 18 10 15 24 8 
H2O-High-1 3.9 66 34 89 73 64 63 67 70 86 79 111 84 104 116 48 
H2O-High-2 6.0 117 57 152 127 101 108 108 140 143 142 258 212 199 240 101 
H2O-High-3 4.2 86 37 116 92 80 76 70 88 122 105 167 147 157 167 67 
Ac-1-Low-1 - 6 - - 5 - - - - 5 - - - - - - 
Ac-1-Low-2 - 8 - - 5 - - - - - - - - - - - 
Ac-1-Low-3 - 8 - - 5 - - - - - - - - - - - 
Ac-1-Mid-1 - 18 - 13 19 9 10 9 12 39 24 10 8 11 11 9 
Ac-1-Mid-2 - 21 - 12 19 7 7 6 11 39 22 18 13 15 19 7 
Ac-1-Mid-3 - 14 - 8 13 - - - 7 29 17 9 7 9 10 - 
Ac-1-High-1 2.2 130 42 144 155 89 91 75 128 401 232 153 134 178 166 98 
Ac-1-High-2 - 115 26 123 145 62 64 53 106 438 227 201 162 186 210 73 
Ac-1-High-3 - 91 21 110 122 53 58 53 90 394 205 130 112 139 145 62 
Ac-2-Low-1 - 6 - - - - - - - 6 - - - - - - 
Ac-2-Low-2 - 7 - - - - - - - 3 - - - - - - 
Ac-2-Low-3 - 8 - - - - - - - 2 - - - - - - 
Ac-2-Mid-1 - 10 - 3 10 - - - - 20 11 - - - - - 
Ac-2-Mid-2 - 20 - 5 18 - - - 7 32 18 - - - - - 
Ac-2-Mid-3 - 12 - 3 11 - - - - 18 10 - - - - - 
Ac-2-High-1 - 45 - 28 63 5 11 - 32 191 98 11 9 13 14 16 
Ac-2-High-2 - 74 - 40 99 5 12 - 46 284 137 15 11 19 19 20 
Ac-2-High-3 - 62 - 43 92 5 17 9 47 266 136 14 11 19 19 23 
Abbreviations: EtG (Ethyl glucuronide); Coc (Cocaine); BE (Benzoylecgonine); NorCoc (Norcocaine); CE (Cocaethylene); Mor (Morphine); MAM (6-Monoacetylmorphine); AcCo (Acetylcodeine); MTD (Methadone); 
EDDP (2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine); Amph (Amphetamine); Meth (Methamphetamine); MDMA (3,4-Methylenedioxy-N-methylamphetamine); MDA (3,4-Methylenedioxyamphetamine); Ritalin 
(Methylphenidate) 
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Table 2 Concentration of BZD-Z in hair locks soaked 10 times in sweat solutions spiked with low, mid or high concentrations. Normalized concentrations of 
BZD-Z in the water, first acetone, and second acetone wash solutions. (*) Approximate value as below LOQ. Concentrations are given as pg/mg.  
Sample Di Nor Tem Ox Lor Brom Mid Hy-Mid Clob Clon Am-Clon Lormet Triaz Fluni 7-AFN Alpr Desflur Zolpidem Zopiclone 
Hair-Low-1 24 23 19 35 23 35 30 25 14 20 9.9* 27 23 17 12 14 22 15 6.9* 
Hair-Low-2 23 23 19 32 21 33 28 24 14 20 9.7* 26 23 16 11 14 23 14 6.2* 
Hair-Low-3 23 20 15 27 18 16* 21 18 11 16 6.5* 20 17 14 8.0 10 19 9.7 - 
Hair-Mid-1 296 281 220 360 271 335 317 284 161 242 204 267 154 306 141 161 257 162 72 
Hair-Mid-2 351 282 238 336 223 200 319 263 185 216 232 228 141 296 122 139 250 146 63 
Hair-Mid-3 266 207 160 219 150 150 213 171 124 152 156 158 88 207 83 93 182 87 38 
Hair-High-1 2930 2561 1966 2902 2114 2474 2790 2405 1485 1984 1886 2154 1195 2623 1052 1318 2248 1265 582 
Hair-High-2 3660 2974 2187 3209 2158 1968 2920 2506 1613 2156 2229 2155 1296 2846 1145 1287 2619 1212 489 
Hair-High-3 2959 2465 1838 2819 1899 1785 2556 2174 1359 1870 1813 1908 1103 2495 1023 1102 2148 1050 420 
H2O-Low-1 2.2 2.1 - - 2.1 - - - 2.2 2.7 - 2.8 - 2.3 1.7 - - 1.9 - 
H2O-Low-2 2.7 2.9 - - 2.3 - - - 1.9 2.4 - - - 2.0 1.6 - - 1.7 - 
H2O-Low-3 1.6 - - - - - - - - - - - - - 1.2 - - 0.9 - 
H2O-Mid-1 32 38 34 23 27 10 26 33 29 36 26 41 42 32 28 28 35 29 18 
H2O-Mid-2 25 30 23 16 21 - 18 24 21 22 19 28 27 23 19 16 23 16 8.5 
H2O-Mid-3 22 25 25 14 17 - 16 22 16 24 17 25 23 20 18 18 22 14 8.5 
H2O-High-1 186 232 183 130 163 20 138 181 136 202 161 221 198 164 155 125 204 106 59 
H2O-High-2 250 302 266 164 221 30 183 254 198 270 213 295 307 232 210 216 276 165 97 
H2O-High-3 218 270 217 157 206 52 195 234 158 230 172 256 240 181 163 155 232 125 70 
Ac-1-Low-1 6.2 6.2 4.8 5.0 4.6 2.9 7.5 6.0 3.9 5.2 - 6.6 6.4 5.1 1.8 3.7 5.7 3.1 1.6 
Ac-1-Low-2 5.1 5.0 4.2 3.3 3.9 2.0 5.3 4.5 3.3 4.4 - 5.4 4.8 4.0 1.2 2.8 4.7 2.4 1.1 
Ac-1-Low-3 4.1 4.1 3.2 2.9 2.4 1.7 5.0 3.1 2.3 2.9 - 3.9 4.0 3.0 - 2.3 3.3 1.5 0.8 
Ac-1-Mid-1 47 48 39 31 34 23 59 44 29 42 6.5 52 46 37 8.5 26 43 24 12 
Ac-1-Mid-2 54 53 43 29 34 15 63 44 35 44 6.7 57 50 43 9.1 28 46 21 8.9 
Ac-1-Mid-3 44 41 31 20 24 12 48 31 24 31 4.1 43 35 30 5.4 20 38 15 6.3 
Ac-1-High-1 534 577 433 388 400 180 623 497 320 479 98 613 524 411 117 298 509 231 108 
Ac-1-High-2 705 727 524 366 435 222 778 583 369 532 89 755 612 478 107 329 622 229 93 
Ac-1-High-3 653 670 482 431 460 245 756 574 343 556 109 695 564 455 131 297 601 212 82 
Ac-2-Low-1 8.9 8.4 6.0 4.9 5.4 3.6 9.8 7.4 4.8 7.1 - 9.1 7.4 6.1 1.0 4.2 7.8 3.0 - 
Ac-2-Low-2 6.4 6.3 4.5 3.2 3.7 2.2 6.6 4.7 3.2 5.3 - 6.8 4.8 4.3 0.6 2.4 5.5 1.9 - 
Ac-2-Low-3 2.9 3.1 2.2 - 1.6 1.3 3.6 2.4 1.5 2.0 - 2.8 2.2 1.8 - - 2.3 1.0 - 
Ac-2-Mid-1 37 34 23 17 19 18 37 25 18 26 - 34 28 23 2.8 15 30 11 4.3 
Ac-2-Mid-2 50 48 38 27 29 17 62 42 29 35 - 48 43 35 4.7 24 42 20 6.9 
Ac-2-Mid-3 33 32 22 16 16 9.6 33 23 16 21 - 30 24 19 2.2 12 28 9.9 4.3 
Ac-2-High-1 377 357 243 183 201 142 370 276 175 251 27 322 265 227 34 146 313 101 38 
Ac-2-High-2 469 480 323 236 256 173 525 404 232 319 34 444 357 295 45 193 405 144 53 
Ac-2-High-3 517 498 324 242 281 176 540 408 219 348 39 444 353 301 50 194 426 150 58 
Abbreviations: Di (Diazepam); Nor (Nordazepam); Tem (Temazepam); Ox (Oxazepam); Lor (Lorazepam); Brom (Bromazepam); Mid (Midazolam); Hy-Mid (Alpha-Hydroxymidazolam); Clob (Clobazam); Clon 
(Clonazepam); Am-Clon (7-Aminoclonazepam); Lormet (Lormetazepam); Triaz (Triazolam); Fluni (Flunitrazepam); 7-AFN (7-Aminoflunitrazepam); Alpr (Alprazolam); Desflur (N-Desalkylflurazepam); 
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3.5. Project Kratom: Development, Validation, and Application of an 
LC-MS/MS Method for Mitragynine and 7-Hydroxymitragynine Analysis in 
Hair 
 
About Project Kratom 
To the best of our knowledge, this manuscript describes the first published hair analysis 
method for mitragynine and 7-Hy-Mitra. A method for mitragynine and 7-Hy-Mitra analysis 
was developed, fully validated, and applied to the entire scalp hair of a self-reported consumer 
of 3 g of Kratom daily to describe the concentration distribution. Additionally, the method 
was applied to 300 routine samples to investigate the prevalence of Kratom consumption in 
our population. The article will be submitted to Drug Testing and Analysis as a short 
communication.  
 
Authors: Ulf Meier, Katja Mercer-Chalmers-Bender, Eva Scheurer, Franz Dussy 
 
Contributions of Ulf Meier: 
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 Development of analytical method 
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3.6. Project CBD: Cannabinoid Concentrations in Blood and Urine after 
Smoking Cannabidiol Joints 
 
About Project CBD 
This publication describes a single person study investigating the possibility of reaching THC 
blood concentrations above the legal threshold for driving in Switzerland after smoking a 
single, legally available, cannabidiol joint. It is a one-participant study that is not part of the 
main work described in this thesis. However, there was an urgent need for some data as 
toxicologist in Switzerland are regularly confronted with CBD cannabis.  
 
Authors: Ulf Meier, Franz Dussy, Eva Scheurer, Katja Mercer-Chalmers-Bender, Sarah 
Hangartner 
 
Contributions of Ulf Meier:  
 Involved in planning the study 
 Interpreting data 
 Writing the article 
 
CRediT Statement: 
Ulf Meier:  Conceptualization, investigation, writing – original draft 
Franz Dussy:   Conceptualization, investigation, writing – review & editing 
Eva Scheurer:  Writing – review & editing 
Katja Bender:  Investigation, writing – review & editing 
Sarah Hangartner: Conceptualization, formal analysis, methodology, investigation, 
supervision, validation, writing – review & editing 
 
 
 
Status: Published 
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4. Discussion, Conclusion, and Outlook 
 
4.1. The Path of the Project 
 
Errors during sample collection are hard to deal with. Much effort is spent on developing and 
validating analytical methods and quantifying accuracy, precision, extraction yields, matrix 
effects, etc. The process of collecting the sample is often neglected and the impact thereof 
underestimated. If a sample is collected that doesn’t represent the target of the investigation, 
the measurement will not yield correct results. This project is aimed at investigating the 
crucial step of sample collection during hair analysis, and whether a lock of head hair from 
any given location is representative for the entirety of the scalp hair. 
 
The overarching path of this project can be described as follows. Project 1 was an exploratory 
study to investigate whether sampling location dependent concentration differences and 
distribution patterns exist and whether the subject was worth a more thorough investigation. 
As the project yielded interesting results, the second study was designed to expand on the first 
study by including many test subjects and expanding the number of investigated substances to 
include DoA and BZD-Z and to increase the EtG sample size. As it was suspected that such a 
study would involve many samples, a combined sample preparation method for EtG, DoA, 
and BZD-Z was developed. With the combined sample preparation method in hand, the study 
was commenced, and 13 participants were recruited. The results of Project 3 supported that 
sweating rates could be an important factor influencing the distribution patterns. Therefore, 
the plausibility of differences in sweat rates being the main factor determining the distribution 
patterns was investigated by taking a closer look at the incorporation of substances into hair 
from sweat. As one study participant reported consuming Kratom, an analysis method for the 
main psychoactive alkaloids mitragynine and 7-Hy-Mitra was developed and the distribution 
patterns were investigated.  
 
The project investigating the cannabinoid concentrations in blood and urine after smoking 
CBD joints had nothing to do with the subject of the thesis. Instead, it was done as there was 
an urgent need for information concerning if smoking CBD hemp could cause blood 
concentrations to reach the Swiss legal cut-off value of THC for driving.  
 
In the following chapters, the results of the individual projects are summarized and generally 
discussed, before discussing their relevance in routine forensic application, recommendations 
for hair sampling, and limitations of the studies.  
 
4.2. Summarized Results 
 
In the following, the results of the individual projects are very briefly summarized. For a more 
extensive presentation of the results including tables, graphs and figures see the corresponding 
sections. 
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The study participant of project 1 showed sampling location dependent EtG and caffeine 
concentrations in his scalp hair. Caffeine concentrations ranged from 1.1 ng/mg to 
12.0 ng/mg, meaning a factor of 10.6 difference between the lowest and highest 
concentration. EtG concentrations ranged from 6.8 pg/mg to 20.2 ng/mg, resulting in a factor 
of 3.0. The caffeine distribution pattern showed higher concentrations towards the edges of 
the haircut (especially on the forehead) and lowest concentration in the vertex region. EtG 
showed lower concentrations at the back of the neck, but otherwise no clear pattern was 
identified. 
 
In project 2, a method for the combined sample preparation of hair samples for subsequent 
analysis for EtG and DoA with LC-MS was successfully developed and fully validated. The 
method facilitated the measurement of the large number of samples of project 3.  
 
Project 3 was the main work of this thesis and yielded by far the most extensive results. 
Thirteen alcohol and/or cocaine consuming participants were recruited for the study. Adding 
the results of the first project yielded a sample size of 10 for EtG and 12 for cocaine. Most of 
the participants consumed many substances and distribution patterns of 29 substances were 
obtained. The factors between minimum and maximum cocaine concentrations of the 
individual participants ranged from 2.8 up to 105 with a mean factor of 17.6. Large 
concentration differences were not unique to cocaine, and factors above 10 could often be 
observed for many of the investigated substances. The distribution patterns of cocaine, most 
other DoA, and some BZD-Z were similar to the pattern observed for caffeine in project 1, 
with higher concentrations on the periphery of the scalp. This distribution shape was found for 
all participants (except for one) and was very similar across participants, although the extent 
of the concentration differences was very substance and participant dependent. EtG also 
showed relevant differences across the scalp, with factors between minimum and maximum 
concentrations of the individual study participants ranging from 2.5 to 7.1, with a mean factor 
of 4.4. The distribution of EtG was often reverse to that of cocaine, with higher concentrations 
in the vertex region. The lowest EtG concentrations were usually found at the back of the 
neck. To describe the distribution pattern, each substance was compared with cocaine using 
Spearman correlations to determine how “cocaine-like” the distributions were. Most DoA and 
BZD-Z showed distribution patterns very similar to the distribution shown by cocaine. The 
perfusion measurements yielded no clear patterns, except for lower perfusion values towards 
the back of the neck. Correlating the perfusion values with the EtG and cocaine 
concentrations yielded statistically significant correlations in half of the cases. In cases with 
significant correlations, the correlation coefficient was positive for EtG and negative for 
cocaine, signifying that higher perfusion rates are correlated to higher EtG and lower cocaine 
concentrations. The correlation was not very strong however, so the perfusion is likely not a 
main contributor to the distribution patterns. Sweat rate measurements yielded a recurring 
pattern of higher sweat rates at the forehead, and generally higher on the periphery of the 
scalp, decreasing towards the vertex. While a direct correlation of sweating results with the 
concentrations was not possible, the pattern of sweating was visually similar to the 
distribution patterns observed for the DoA/BZD-Z. Consequently, differences in sweat rates 
could be a main contributor to the concentration distribution patterns and most DoA and 
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BZD-Z could be incorporated into the hair from sweat, while EtG is more likely washed out 
of the hair by the sweat.  
 
No definite results can be presented yet for the incorporation of substances into hair from 
spiked artificial sweat solutions. The preliminary results show that all substances can enter the 
hair from spiked sweat solutions. The concentrations found in or on the hair are substance 
dependent. EtG showed the lowest concentrations after soaking of all tested substances. Of 
the DoA, benzoylecgonine showed the lowest and methadone the highest concentrations. 
 
A method for the measurement of mitragynine and 7-Hy-Mitra in hair was successfully 
developed and validated according to the guidelines of the GTFCh. Mitragynine 
concentrations in the hair of the self-reported consumer were between 1.1 ng/mg and 
2.2 ng/mg (mean 1.5 ng/mg). 7-Hy-Mitra was not detected in any sample. No clear 
distribution pattern was observed for mitragynine concentrations. The measurement of 300 
hair samples from our routine analysis population did not reveal a single positive result. This 
shows that the prevalence of Kratom consumption is likely low in our population of mostly 
people in drivers-license regranting procedures.  
 
Project CBD demonstrated that THC blood concentrations above the legal threshold for 
driving in Switzerland could be reached shortly after smoking a joint with CBD rich cannabis. 
Maximum THC concentrations of 2.7 ng/mg and 4.5 ng/mg were reached after the single and 
chronic smoking experiments, respectively. CBD concentrations reached 45.7 ng/ml and 
82.6 ng/ml after the single and chronic smoking experiments, respectively. No accumulation 
of THC in blood or urine could be detected during the 10-day smoking period. A slight 
accumulation of THC-COOH in urine is possible. 
 
4.3. General Discussion 
 
Incorporation via the bloodstream, incorporation via sweat or sebum, and incorporation from 
external sources are considered the three main incorporation pathways of substances into the 
hair (see section 1.5). It is likely that incorporation of a substance into the hair happens via a 
combination of these pathways. Concentration differences across the scalp show that the 
amount being incorporated through one or more of these pathways is scalp-location 
dependent. As the extent of the concentration differences is substance and participant 
dependent, it is likely that the portion that each pathway contributes to the concentration in 
the hair is also substance and participant dependent. As the distribution of the sweat rates is 
similar to the concentration distribution pattern for the “cocaine-like” substances, it is likely 
that the sweat rates govern the shape of the distribution. The perfusion rates were lower on the 
neck but otherwise no pattern was observed across participants. Therefore, differences in the 
perfusion rates across the head likely do not cause the observed concentration distribution 
patterns. The following can be hypothesized:  
The incorporation through blood is largely uniform across the head while the incorporation 
via sweat is dependent on local sweat rates and is responsible for concentration differences 
across the scalp. The portion of the concentration in the hair that each pathway is responsible 
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for is substance dependent, head location dependent, and influenced by interindividual 
factors.  
If sweat rate differences are responsible for the concentration differences across the head, 
substances must be able to transitions from the blood into the sweat and then from the sweat 
into the hair. As the extent of the differences across the head is substance dependent, 
substances likely differ in their propensity for one or both transitions. Cocaine-like substances 
that show larger concentration differences across the head would be incorporated into the hair 
to a larger portion through the sweat. These transition steps should be investigated thoroughly 
in future studies.  
Fairly small changes in the chemical structure can strongly impact the distribution as can be 
seen from the extent of concentration differences and how cocaine-like morphine and codeine 
are compared to 6-monoactelymorphin and acetylcodeine. The acetylated substances show 
more cocaine-like and more extreme concentration differences than their non-acetylated 
counterparts. Therefore, lipophilicity might play an important role for incorporation via sweat. 
For some substances, the extent of differences is highly participant dependent, which could be 
caused by e.g. differences in sweat pH, hair structure, co-consumption of substances, 
differences in metabolism, or amount of consumed substance. 
The soaking experiments that are currently underway are meant to test the ability of the 
substances to enter the hair from the sweat. The preliminary results do not contradict this 
hypothesis. However, the observed concentration differences after 10 soaks do not align with 
the differences in the extent of concentration distribution across the scalp. Of the DoA, 
methadone showed some of the smallest differences across the scalp but in the soaking pre-
experiments showed the highest hair concentrations while benzoylecgonine generally showed 
large differences across the scalp but the lowest incorporation of the DoA in the soaking 
experiment. Therefore, the transition from blood to sweat is likely the dominating factor 
determining the distribution patterns. A more thorough discussion can be held when definite 
results from the soaking experiments are available. 
Unfortunately, there is little to no literature available on sweat concentrations in relationship 
to blood concentrations for the investigated substances. The propensity of substances to enter 
the sweat from the blood should be investigated in future studies and be compared with the 
extent of the concentration differences across the scalp of the different substances. 
 
4.4. Relevance of the Results for Routine Forensic Applications 
 
The large concentration differences described herein are highly significant for routine 
applications for many reasons and should be considered during the sampling protocols of 
laboratories doing routine work. Cut-off values are often applied in forensic hair analysis, 
especially for abstinence testing for e.g. driving-license regranting. It is the nature of cut-off 
values that the decisions are binary; either the value is above (positive) or below (negative) a 
given cut-off. When the concentration of a substance in a hair lock is close to the cut-off, 
measurement error can cause repeated measurements of that lock to sometimes yield positive 
and sometimes negative results. While cut-off values are very practical and should allow a fair 
and reproducible judgement, this is an intrinsic problem of cut-off values. A serious problem 
arises, if a factor with a large influence on the results, such as sampling location of hair on the 
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head, is not considered or controlled. In this case, sampling from a different location can 
cause the result of the test subject to be interpreted completely differently. This is illustrated 
well by regarding study participant 10 of project 3. This participant showed concentrations of 
EtG ranging from 6.2 pg/mg up to 30.4 pg/mg. If applying the SoHT recommended cut-offs 
for EtG of 7 pg/mg (5 pg/mg according to the new SoHT consensus of 06.08.2019
106
) for 
abstinence and 30 pg/mg for chronic excessive consumption, this participant would be 
classified as in accordance with a self-declared abstinence (if applying the former cut-off), a 
social drinker, or a chronic excessive consumer, depending on from where the hair lock was 
taken. For seven of the ten study participants, EtG concentrations fell into more than one 
category. A similar thing occurs when applying the SoHT recommended cocaine cut-off value 
of 500 pg/mg to study participant 7. This participant showed cocaine concentrations ranging 
from 312 pg/mg to 4773 pg/mg, so would also be judged differently depending on sampling 
location. As previously stated, measurement errors can cause some values to be below or 
above a given cut-off when the concentration is close to the cut-off. This is different however, 
in that 312 pg/mg is not particularly close to the 500 pg/mg cut-off and 4773 pg/mg is 9-fold 
above the cut-off. These cases clearly illustrate that if hair sampling location is not controlled, 
the interpretation of results when applying cut-offs is sampling site dependent. Even in cases 
where cut-offs are not applied, differences across the scalp can lead to different interpretations 
of the consumption behavior, in the sense that even though it is not possible to calculate the 
consumed dose of a substance from hair concentrations, many laboratories do classify hair 
concentrations roughly as e.g. low, mid, or high compared to the concentrations otherwise 
measured at that laboratory.  
In forensics, the ability to confirm results is very important. Usually, at least two locks of hair 
are sampled; one is measured, and another is kept in reserve for confirming the result in case 
e.g. the test subject does not accept the result. If these locks of hair are taken from different 
head areas, the second measurement will not necessarily confirm the first measurement. This 
is an uncomfortable situation for the forensic toxicologist as they do not know the cause of the 
discrepancy. It could be a bad calibration, a sample mix-up, or many other things. Even if the 
toxicologist is aware that the hair locks were taken from different places, large concentration 
differences could be a hard sell if the results need to be presented to judge or jury in court.   
External contamination of hair is a large concern in hair analysis as it can lead to false 
positive results. A strategy to counter this is to rely on metabolites of a substance and to use 
metabolite-parent substance ratios to classify a result as external contamination or uptake of a 
substance. This ratio classification is usually done using a method dependent cut-off. The 
results of project 3 show that due to the different extents of concentration differences of e.g. 
cocaine, benzoylecgonine, and norcocaine, the metabolite-parent ratios are also sampling site 
dependent. The same considerations concerning cut-offs also apply here, and the classification 
as external contamination or consumption can in some cases be sampling location dependent.  
In studies looking at dose-concentration relationships in hair, the linearity is often poor. This 
is likely due to the many factors affecting the incorporation of substances into the hair, as 
described in the introduction. If the sampling location was not strictly controlled during these 
studies, sampling location can be another factor affecting the results. Therefore, if efforts are 
to be made to ever establish dose-concentration relationships, the sampling location should be 
considered and controlled.  
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The results of the soaking experiments of project 4 will be relevant for routine forensic hair 
interpretation. From the preliminary results it seems that all tested substances enter the hair 
and can be incorporated strongly enough to not be removed by the applied standard washing 
procedure. This is problematic for interpretation of results as it opens up the possibility of 
transfer of substances of a consumer to a non-consumer via sweat, including drug metabolites.  
 
The combined sample preparation method that was developed to deal with the large number 
of samples of project 3 has proven valuable in routine work. In cases with little available hair, 
using the combined method, an analysis for EtG and DoA and BZD-Z is possible. Our lab is 
relatively small, and we do not have many samples for which multiple analyte groups are 
requested (in 2018: Total ca. 860, EtG ca. 470, DoA + BZD-Z ca. 390, EtG + DoA or BZD 
140). Therefore, the combined method is not regularly used. For larger labs with more 
samples for which a broad range of analytes is requested, this method could greatly reduce 
sample preparation time and reduce the amount of required hair.  
 
No method for measuring mitragynine and 7-Hy-Mitra in hair had previously been published. 
Kratom falls under varying legal classifications around the world and the legality of Kratom 
has seen a lot of change in the last few years. Especially in the USA, Kratom consumption 
seems to have gained popularity. Therefore, the study on mitragynine distributions in hair of a 
regular consumer could be useful for toxicologists if the question of detecting Kratom 
consumption in hair ever arises. 
 
With the legal availability of CBD rich cannabis with THC concentrations below 1% in 
Switzerland, the question of whether the consumption of CBD cannabis could cause THC 
levels to rise above the cut-off for driving became urgent. The one-person experiment showed 
that for a short time after consuming a CBD joint, concentrations above this level could be 
found in blood. After about 30 minutes, concentrations of THC were again below the cut-off. 
This is a one-person experiment and more thorough studies are needed to investigate typical 
concentrations levels of cannabinoids after consuming CBD material. The effects that CBD or 
the combination of CBD and THC might have on driving capacity need to be investigated. 
This study can serve as a starting point for planning these studies. In fact, a larger study has 
recently been commenced at our institute to investigate the effects of CBD on driving 
capacity.   
 
4.5. Recommendations for Hair Sampling 
 
We recommend following the recommendations of the SoHT and the EWDTS to sample hair 
from the vertex posterior and to sample adjacent hair locks. Following the current 
recommendation has three main benefits:  
Firstly, the vertex posterior is the established sampling region. Most research on hair analysis 
has been done in this region, meaning it is the best described area, and the cut-off values were 
established in parts based on results obtained from this region. The metabolite-parent ratios 
were also studied in hair from this region. Considering the massive concentration differences 
described in this study, the cut-offs recommended by e.g. the SoHT should, depending on the 
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question to be answered, not be applied to hair taken from other regions. At the very least, it 
should be documented from where the hair was sampled.  
Secondly, the data suggest that the concentrations in the vertex area are more homogenous 
than elsewhere. The concentration gradients are steeper towards the periphery of the scalp. 
This homogeneity has the large benefit that hair locks taken directly adjacent to each other 
will have a higher likelihood of containing comparable concentrations. This is very beneficial 
when results need to be confirmed. 
Thirdly, for the analysis of EtG, the vertex is suitable as the concentrations are higher in this 
area. EtG is a low concentration marker,
107-109
 and measuring low EtG concentrations can be 
analytically demanding. Sampling from another region might necessitate lowering the EtG 
cut-off to retain the sensitivity of the cut-off, making analysis even more demanding. In some 
cases, a maximum sensitivity for DoA and BZD-Z might be required, and cut-off will not be 
applied. In such a case it could be reasonable to sample from the periphery of the scalp to 
increase the chance of detecting the analytes. If this approach is used, the interpretation 
should take into account that the metabolite-parent ratios could be lower. In the authors’ 
opinion, the periphery of the haircut and especially the forehead might more likely be 
externally contaminated than the hair at the vertex. Therefore, this should be investigated 
before we can fully recommend such an approach.  
In summary, hair samples should be taken from the vertex posterior and directly adjacent to 
each other. The location of sampling should be documented, especially if sampling was done 
in a different region or the strands were not taken adjacent to each other. If strands from non-
vertex regions are used, the interpretation of the results should take this into consideration and 
the results should be interpreted carefully by an expert in this field. 
 
4.6. Limitations of the Projects and Applied Methodologies 
 
Even though the projects were very successful, as always there would have been some room 
for improvement. The major limitations of project 1 are clearly that it was a one-person study 
and EtG was the only investigated forensically relevant substance. These limitations were 
fully addressed in project 3. Project 1 did not address the pathways for incorporation, but 
project 3 did partially address this limitation as well. The method for caffeine measurement 
was not fully validated. However, the most important parameters were assed and the exact 
values in the hair are not important, so this is only a minor limitation.      
 
In project 3 there were several limitations. Firstly, sebum as a possible incorporation pathway 
was not investigated. While there are a number of possible ways to collect sebum such as 
Sebutape® or cigarette paper,
110
 the amount of sebum is hard to quantify as sebum cannot be 
collected without also collecting sweat, and the quantification of sebum amounts often 
requires specialized instruments such as Sebumeter® or Glossymeter®. Also the excretion 
rate of sebum is rather low, so collection would have had to be done over a longer time 
period.
111
 As this was not practical for the study, the sebum excretion rates were not 
measured. 
Secondly, a direct correlation of the sweat rates with the concentration data was not possible. 
This was not possible as the size and orientation of the sweat pads were different than the 
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sampled hair areas. Also, the exact sweat pad locations on the head in regard to the hair 
sample areas were not perfectly described. Therefore, only a visual comparison of the 
distributions could be done. In retrospect, it would have been beneficial to make more photos 
or videos of the head after sampling and during sweat collection. The photos could have been 
made in a way to allow the creation of a 3D-model. With the 3D-model, exact locations of 
sweat pads and sample areas could be overlaid and some calculations would have been 
possible. Still, from the visual assessment it is apparent that the sweating rates show a similar 
pattern as the hair concentrations of most DoA and BZD-Z. The method for sweat 
measurement was not validated. However, similar methods using sweat pads made of the 
same material have been validated.
112
 The only notable change is the arrangement of many 
sweat pads on a cycling cap.  
Thirdly, the head skin perfusion measurement with laser Doppler anemometry suffers from a 
few limitations. Pre-experiments had shown that the hair stubbles that remain after cutting the 
hair negatively influenced the results of the laser Doppler measurement. To eliminate this 
factor, the heads of the participants were shaved after cutting the hair. While this improved 
the measurement, the shaving process sometimes caused some skin rashes. Theses rashes 
showed much higher perfusion rates than the surrounding skin. A close visual inspection of 
the head was done, and photographic notes of any skin damage were made. These areas were 
not included in the perfusion measurements. It is likely that occasionally some damage was 
not seen which could cause perfusion rates to be too high in a few areas. A more crucial 
limitation is that the penetration depth of the used laser is about 0.3-0.4 mm.
113
 The perfusion 
in the skin is supplied via two horizontal layers of blood vessels, the upper subpapillary 
plexus and the lower dermal plexus.
25
 The hair roots are supplied via the dermal plexus. The 
perfusion measurement likely mainly measured the blood flow in the subpapillary plexus. The 
two layers are connected via many vertical blood vessels, and we assume that the perfusion in 
one layer is representative of the other. However, the perfusion results should be interpreted 
with caution. Other methods to measure the perfusion were considered. A lab focusing on 
optical coherence tomography,
114
 which is regularly applied in ocular biometry, and has been 
used to image the microcirculation in mice ears and even of human skin in vivo
115,116
 was 
contacted to see if this method could be applied to image the scalp microcirculation. 
Unfortunately, the methodology proved to be unsuitable for scalp skin. Using MRI 
measurements for imaging the microcirculation was considered, but the use of contrast agents 
was not an acceptable option and the resolution would have been an issue. Therefore, we 
decided to use the laser-Doppler imaging technique.  
Fourthly, no female participants were enlisted. This was expected, as DoA consumption is 
more common in men than in women in Switzerland and men were expected to be more 
willing to part with their hair. 
Fifthly, the self-reported consumption data is probably not very reliable. Participants were 
asked about their alcohol, DoA and BZD-Z consumption in a non-influencing way to avoid 
guiding their answers. However, many of the substances that were detected in the hair had not 
been reported. Often, no exact amounts for the drug consumption could be reported. 
Therefore, it was not attempted to correlate self-reported doses with hair concentrations.  
 
As project 4 is still underway, it is too early to discuss limitations in detail, yet some 
limitations are immediately apparent. The study sets out to “realistically” contaminate the hair 
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with sweat containing EtG, DoA and BZD-Z. While definitely using more realistic conditions 
for incorporation via sweat than other conducted studies focusing on external contamination, 
it is hard to say what realistic actually means. The amount a person sweats, how often this 
person washes their hair, and countless other factors such as hair porosity, hair damage, hair 
length, etc. could be potential factors influencing the incorporation. Ultimately, the only time 
truly realistic conditions are certain, is in real life. In vivo studies have their own problems 
such as doing controlled studies, reproducibility, etc. Another limitation is uncertainty about 
the expected concentrations in the sweat. The concentrations of DoA/BZD-Z in the artificial 
sweat solution used in the study are estimated very roughly based on studies in which sweat 
patches were applied for abstinence testing or after controlled administration. Unfortunately, 
the amount of sweat that was secreted to produce the concentrations was not measured, so the 
concentrations in the sweat cannot be calculated. Instead, average sweat secretion rates were 
assumed to estimate the sweat concentrations. This is of course a large source of uncertainty 
for this study which is why a large concentration range was chosen for the low, mid, and high 
concentration levels. Another reason for this wide concentration range is that the consumed 
amounts of drugs also vary widely between consumers. Even with these limitations, we 
believe that by “realistically” modeling exposure and sweat concentrations, the study will 
provide valuable insights regarding to what extent substances can enter the hair through the 
sweat and if sweat rate differences are a possible explanation for the observed concentration 
differences across the scalp. 
 
The major limitation of the Kratom project is of course that it is a one-person study. However, 
the study provides a valuable reference value for mitragynine concentrations in hair of a daily 
consumer, especially as the study participant reported very regular consumption of 3g/d. A 
limitation of the used methodology is that the LOD and LOQ of 7-Hy-Mitra were rather high. 
This might be the reason that no 7-Hy-Mitra was detected in any hair sample of the daily 
consumer. The LC-method as well as the ion source parameters could not be optimized for 7-
Hy-Mitra, as the analytes were integrated into an existing DoA/BZD-Z method. Maybe some 
sensitivity gain would have been possible by optimizing all parameters for 7-Hy-Mitra. 
Mitragynine and 7-Hy-Mitra were chosen as they are the main psychoactive substances in 
Kratom. However, there are many more alkaloids in Kratom such as e.g. paynantheine, 
speciogynine, or speciociliatine, and some of these might have been better choices for 
detecting Kratom consumption. This would have to be further investigated if Kratom turns out 
to be a substance that needs to be regularly monitored. 
 
The key limitation of the CBD study is that it is a one-person study. This was done as some 
information on THC blood levels after smoking CBD joints was needed quickly, as judging 
from the availability of CBD products in Swiss stores, CBD consumption is wide spread in 
Switzerland. As it is a one-person study, the results should of course be treated cautiously. 
Large intra-individual differences can be expected, especially considering that smoking is not 
a very standardized procedure. Studies with many participants, with longer application times, 
with more standardized methodologies, and with actual measurement of impairment are 
needed to judge the effects of CBD cannabis on driving capacity and fitness. Such a study has 
recently commenced at our institute. An additional limitation of the study was insufficient 
blood sampling frequency at the beginning of the experiment. Therefore, it is likely that the 
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true THC and CBD maxima in blood were missed. While this is not very important for this 
study, it would be good to characterize the pharmacokinetics more thoroughly in future 
studies.  
 
4.7. Conclusion and Outlook 
 
In summary, sampling location dependent hair concentration differences were thoroughly 
characterized for EtG, DoA, and BZD-Z for a collection of study participants using a newly 
developed method for the combined sample preparation of hair samples for the measurement 
of these substance classes. Large differences were observed with higher concentrations of 
most DoA and BZD-Z on the periphery of the haircut. EtG showed a reverse behavior to 
cocaine and the highest concentrations were found in the vertex region. The head skin 
perfusion rates and the head sweat rates were also characterized and compared with the 
concentration distribution patterns. From this comparison, we suspect differences in sweating 
rates to be largely responsible for the observed concentration differences. Perfusion 
differences likely only play a minor role. The plausibility of sweating as the major source of 
the concentrations differences is currently being investigated in a soaking experiment. As a 
side projects, a method for the measurement for mitragynine and 7-Hy-Mitra in hair was 
developed and was successfully applied to the hair of a regular Kratom user. The method was 
also applied to 300 routine samples which all tested negative for mitragynine. The CBD 
cannabis smoking study showed that after smoking a CBD joint, THC levels could rise above 
the legal cut-off concentration in blood for driving in Switzerland.  
The results of the concentration distribution studies are important as they can influence 
recommendations for hair sampling. Additionally, the results can rationalize if large 
concentrations differences are found in a confirmation analysis. These concentration 
differences can regularly lead to hair results being interpreted differently when applying cut-
offs depending on hair sampling location. It is not fair that a person should be judged 
differently depending on where a hair sample is taken. Hair samples should be taken at the 
vertex posterior as the recommended cut-off values by e.g. the SoHT are defined based on 
measurements from this area. It is unfortunately often not possible to sample hair from the 
vertex posterior due to e.g. male pattern baldness. These cases needed to be carefully 
interpreted. In the future, it should be discussed if applying the recommended cut-off values 
to hair taken from a different head region should be allowed at all, or if head region specific 
cut-offs need to be defined. 
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